What You Should Know:
- The American Cancer Society (ACS) and Color Health have joined forces to launch a new pilot program aimed at increasing access to colorectal cancer screening in underserved communities.
- The program, recognized by the White House Office of Science and Technology Policy, seeks to address disparities in cancer outcomes and improve early detection rates.
The Importance of Colorectal Cancer Early Detection
Colorectal cancer is highly treatable when
Read More
Color
OpenAI, Color Health Launch Cancer Copilot Tool To Expedite Cancer Treatment
What You Should Know:
- Cancer – the second leading cause of death in the United States – is a complex disease requiring timely diagnosis and treatment. Delays in either can significantly impact patient outcomes.
- Color Health, a company dedicated to improving access to healthcare, has partnered with OpenAI to pioneer a new solution: the copilot application. This innovative tool utilizes artificial intelligence (AI) to streamline cancer care and expedite treatment plans.
A
Read More
Accenture Report Reveals Staggering Health Inequities and the Role of US Healthcare Ecosystem in Addressing Them
What You Should Know:
- Health equity – or the lack thereof – is one of the biggest challenges facing US healthcare organizations today.
- A new report from Accenture, US health inequity: beyond the statistics, analyzes the role US healthcare ecosystem participants can play in addressing health inequities due to race and ethnicity. The statistics are staggering.
Analysing Key Trends Concerning Health Inequities
To understand the human and economic
Read More
Addressing the Diversity Challenge in Clinical Research Through Patient Advocacy
Diversity is paramount to the success of clinical research, both ethically and scientifically. Without adequate representation of racial and ethnic minorities, investigators lack an understanding of the safety and efficacy of novel treatments within those groups. From a scientific standpoint, an incomplete dataset hinders drug delivery and the development of breakthrough therapies – but from an ethical standpoint, underrepresentation creates a barrier to treatment options for populations that
Read More
Clarius Awarded FDA Clearance for AI Ultrasound Musculoskeletal Imaging App
What You Should Know:
- Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, receives 510(k) clearance for its new MSK AI model, which automatically identifies and measures tendons in the foot, ankle, and knee using artificial intelligence (AI).
- The new MSK AI model will be available soon with the Clarius L7 HD3 and Clarius L15 HD3 high-frequency, wireless handheld ultrasound scanners.
AI Driven Imaging To Improve
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.
There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
39 Organizations Sign Global Heath Equity Pledge to Advance Health Equity Globally
What You Should Know:
- Today, World Economic Forum announced that 39 organizations have signed the Global Health Equity Network Zero Health Gaps Pledge.
- The pledge includes 10 key commitments all signatories have made to embed health equity principles throughout their operations, workforce and guiding philosophies. It marks the beginning of an historic journey to making health equity an integral part of business strategies globally and an important step towards a world without health
Read More
How Tech Can Improve Health Plan Performance & Star Ratings in 2023 & Beyond
The open-enrollment period that recently concluded for U.S. health plans was the first since the expiration of pandemic-linked changes to how Star Ratings were calculated. This is a period of major transition for the industry, with some health plans struggling to maintain their previous ratings and plan participants, who are now accustomed to home-based testing and treatment, expecting those services and features to continue. Fortunately, new technology can help health plans boost plan
Read More
Why The Future of Lateral Flow Testing is Digital
Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’ (Dx) practice, as well as a growing range of applications outside healthcare. LFT's capacity for delivering fast turnaround—rapid detection in less than 20 minutes—from sample to result has made LFTs central to the shift moving triage and primary care closer to the patient at point-of-care (POC) and point-of-need (PON).
Being intuitive for the user,
Read More
AI/ML Used for Clinical Trial-Site Identification Simultaneously Improves Enrollment Rates and Diversity
Ethnic and racial minorities are commonly underrepresented in clinical trials. This problem is so severe that in April, the U.S. Food and Drug Administration (FDA) expanded upon existing guidance to further emphasize recommendations to sponsors developing treatments to increase enrollment from underrepresented populations in the U.S., including African-American, Hispanic, Asian and other persons of color, in clinical trials. In the updated guidance, the FDA provided details on what sponsors
Read More
